Cooper Companies Inc (NYSE:COO) Director Stanley Md Zinberg sold 5,000 shares of the business’s stock in a transaction on Thursday, January 4th. The stock was sold at an average price of $224.66, for a total value of $1,123,300.00. Following the completion of the transaction, the director now directly owns 6,090 shares of the company’s stock, valued at $1,368,179.40. The transaction was disclosed in a legal filing with the SEC, which is available at this link.
Shares of Cooper Companies Inc (NYSE:COO) traded down $3.74 on Thursday, hitting $228.64. The stock had a trading volume of 660,263 shares, compared to its average volume of 517,745. Cooper Companies Inc has a 1 year low of $175.73 and a 1 year high of $256.39. The company has a quick ratio of 1.26, a current ratio of 2.41 and a debt-to-equity ratio of 0.36. The stock has a market capitalization of $11,170.00, a P/E ratio of 30.40, a price-to-earnings-growth ratio of 1.86 and a beta of 0.54.
Cooper Companies (NYSE:COO) last issued its quarterly earnings results on Thursday, December 7th. The medical device company reported $2.65 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.64 by $0.01. The company had revenue of $561.50 million for the quarter, compared to the consensus estimate of $558.86 million. Cooper Companies had a return on equity of 16.02% and a net margin of 17.43%. Cooper Companies’s revenue for the quarter was up 8.3% on a year-over-year basis. During the same quarter in the prior year, the business posted $2.28 earnings per share. equities research analysts expect that Cooper Companies Inc will post 11.51 EPS for the current fiscal year.
The company also recently announced a semiannual dividend, which will be paid on Friday, February 9th. Stockholders of record on Tuesday, January 23rd will be given a $0.03 dividend. The ex-dividend date is Monday, January 22nd. This represents a dividend yield of 0.03%. Cooper Companies’s dividend payout ratio (DPR) is presently 0.80%.
Several hedge funds and other institutional investors have recently added to or reduced their stakes in COO. Janus Henderson Group PLC lifted its position in shares of Cooper Companies by 558.5% in the second quarter. Janus Henderson Group PLC now owns 2,175,791 shares of the medical device company’s stock valued at $520,937,000 after acquiring an additional 1,845,368 shares in the last quarter. Koch Industries Inc. acquired a new stake in shares of Cooper Companies in the second quarter valued at approximately $312,000. Voya Investment Management LLC increased its holdings in shares of Cooper Companies by 973.4% in the second quarter. Voya Investment Management LLC now owns 329,015 shares of the medical device company’s stock valued at $78,773,000 after purchasing an additional 298,363 shares during the last quarter. American Century Companies Inc. increased its holdings in shares of Cooper Companies by 471.0% in the third quarter. American Century Companies Inc. now owns 316,233 shares of the medical device company’s stock valued at $74,982,000 after purchasing an additional 260,847 shares during the last quarter. Finally, Westfield Capital Management Co. LP increased its holdings in shares of Cooper Companies by 47.8% in the third quarter. Westfield Capital Management Co. LP now owns 636,882 shares of the medical device company’s stock valued at $151,011,000 after purchasing an additional 206,003 shares during the last quarter. Institutional investors and hedge funds own 96.73% of the company’s stock.
Several research analysts have recently commented on COO shares. Robert W. Baird set a $273.00 target price on Cooper Companies and gave the company a “buy” rating in a research report on Monday, October 16th. BMO Capital Markets reaffirmed a “buy” rating and set a $272.00 target price on shares of Cooper Companies in a research report on Friday, October 13th. Zacks Investment Research raised Cooper Companies from a “hold” rating to a “buy” rating and set a $265.00 target price on the stock in a research report on Tuesday, October 10th. Stifel Nicolaus reissued a “buy” rating and issued a $265.00 price objective (down from $275.00) on shares of Cooper Companies in a report on Friday, December 8th. Finally, Raymond James Financial reissued a “buy” rating and issued a $265.00 price objective on shares of Cooper Companies in a report on Monday, December 4th. Seven analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. Cooper Companies presently has an average rating of “Buy” and an average price target of $259.70.
TRADEMARK VIOLATION WARNING: “Insider Selling: Cooper Companies Inc (NYSE:COO) Director Sells 5,000 Shares of Stock” was first published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this article on another site, it was copied illegally and republished in violation of U.S. and international trademark and copyright law. The correct version of this article can be viewed at https://www.dispatchtribunal.com/2018/01/11/stanley-md-zinberg-sells-5000-shares-of-cooper-companies-inc-coo-stock.html.
About Cooper Companies
The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.